![]() Intensity Therapeutics Intensity Therapeutics is a biotechnology company that develops intratumoral immunotherapy products. | ![]() OncoTherapy Science OncoTherapy Science is a company engaged in research and development of cancer therapeutics. | ![]() Acrivon Acrivon (also known as Acrivon Therapeutics) is a clinical-stage oncology company that leverages a precision medicine platform called Acrivon Predictive Precision Proteomics (AP3) for the development of a drug pipeline. | |
Founding Date | Founding Date 2012 | Founding Date 2001 | Founding Date 2018 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Shelton, US HQ | Locations Kawasaki, JP HQ | Locations Watertown, US HQ Lund, SE |
Employees | Employees 5150% increase | Employees 54 | Employees 415% increase |
Valuation ($) | Valuation ($) 42.7 m | Valuation ($) 56.9 m | Valuation ($) 256.1 m |
Financial | |||
Net income | Net income ($11.6m) (FY, 2025) | Net income (¥910.6m) (FY, 2026) | Net income ($77.9m) (FY, 2025) |

OncoTherapy Science is a company engaged in research and development of cancer therapeutics.
View company
Acrivon (also known as Acrivon Therapeutics) is a clinical-stage oncology company that leverages a precision medicine platform called Acrivon Predictive Precision Proteomics (AP3) for the development of a drug pipeline.
View company